Clinical Trials Browser

Phase 3 × Urinary Tract Infections × Ertapenem × Clear all

NCT03218800 2022-08-11

Ertapenem Administered Subcutaneously Versus Intravenously

Phase 3 Terminated

Urinary Tract Infections